:: 
Deadline FP7 eHealth - 3.2. QUALITY, EFFICIENCY AND SOLIDARITY OF HEALTHCARE SYSTEMS INCLUDING TRANSITIONAL HEALTH SYSTEMS
Submitted by consen on Wed, 2008-10-15 14:18.
3.2. QUALITY, EFFICIENCY AND SOLIDARITY OF HEALTHCARE SYSTEMS INCLUDING TRANSITIONAL HEALTH SYSTEMS
The objective is to provide, in the light of new knowledge, scientifically validated tools to
allow countries to learn from the experience of other health systems and their
sustainability, taking into account the importance of national contexts and population
characteristics (ageing, mobility, migration, education, socioeconomic status and the
changing world of work etc). Focus will be on organisational, financial and regulatory
aspects of health systems (assessing the cost, efficiency and benefits of different
interventions including as regards patient safety), their implementation and their outcomes
in terms of effectiveness, efficiency and equity (including disadvantaged groups). Special
attention will be paid to investment issues and human resources, including home care
strategies.
Expected impact: Projects should advance the state of the art in the field of health systems
research and enhance cooperation between researchers in Europe and other geographic
regions to promote integration and excellence of European research in the field. This
research should develop the scientific evidence base that supports the Member States to
organise better their health systems according to the common principles of equity,
solidarity, and universality. The knowledge generated should empower the policy and
decision maker better to manage and reform healthcare systems in view of common
challenges and within the common framework of the European Union.
Topics for single-stage submission and evaluation; deadline 3 December 2008:
- HEALTH-2009-3.2-1: Organisation of dementia care. FP7-HEALTH-2009-
single-stage. Assess European health and social care systems as regards the
organisation and financing of prevention, diagnosis, medical treatment and social
care for dementia patients. Identify/develop approaches/models that can be
integrated into existing European health and social care systems which addresses
the need for specific care and living conditions, the specificities of formal and
informal care arrangements, and supports families living with dementia patients
for more effective and sustainable dementia care in Europe. Findings of this
research should enable national decision makers to base their decisions on the best
knowledge available when they reform the organisation of dementia care.
Funding scheme: Collaborative Project (Small or medium-scale focused research
project).
- HEALTH-2009-3.2-2: Healthcare outcomes and cost-benefits. FP7-HEALTH-
2009-single-stage. Investigate the relationship between quality of care with costs,
efficiency, and accessibility by identifying and assessing existing approaches.
Develop/identify approaches/models to describe the balance between quality of
care and costs, taking patient satisfaction and the benefits of healthcare into
account. Analyse how the transition of changing treatment practice is tackled
across Europe. A multi level approach is needed, also taking into account the
diversity of European health systems (e.g. degree of centralisation, models of
financing, and cultural and historical determinants of models). Findings should
support national decision makers when reforming health systems and aim to
support development of the European Community Health Indicators managed by
the European Commission's Directorate-General for Health and Consumer
FP7 Cooperation Work Programme: Health
Page 31 of 62
Protection. Funding scheme: Collaborative Project (Small or medium-scale
focused research project).
- HEALTH-2009-3.2-3: Primary care quality linkage to costs. FP7-HEALTH-
2009-single-stage. The focus should be on the analysis of different organisational
models for primary care treatment across Europe and to develop models linking
the quality of care to costs, taking into account access, self payment, equity issues
and patient satisfaction. Relationship between primary and secondary care should
be explored including different models of 'gate keeping', and how quality and costs
in primary care are affected. Recommendations on best practice should be
developed and results should support Member States when they reform the
organisation of primary care. Funding scheme: Collaborative Project (Small or
medium-scale focused research project).
- HEALTH-2009-3.2-4: Impact of cross border collaboration on health
services. FP7-HEALTH-2009-single-stage. Identify and analyse arrangements of
cooperation between actors located in different EU countries that aim to transfer
patients, providers, products, services, funding or knowledge across the border
which separates them. Current gaps in documentation of already existing crossborder
collaboration activities as regards geographical coverage, availability and
quality of data need to be addressed. On this basis a systematic in-depth analysis
of the potential impact of cross-border collaboration on the wider healthcare
system should be undertaken. Primary data collected in this project should close
existing gaps and the findings of this research should enable national and
European decision makers to correctly assess the scale of existing cross border
care cooperation and its potential implications for the national healthcare system.
Funding scheme: Collaborative Project (Small or medium-scale focused research
project).
- HEALTH-2009-3.2-5: Research access to comparable healthcare data. FP7-
HEALTH-2009-single-stage. Identify and analyse the availability and
comparability of healthcare related data and the access for health services
researchers to this data across EU member states. Develop recommendations to
improve access to healthcare related data for health services researchers taking into
account national barriers and opportunities for more effective comparative crossnational
health systems research. Account should be taken of existing data (e.g. as
maintained by OECD, WHO, EUROSTAT). Funding scheme: Coordination and
Support action (Coordinating action).
- HEALTH-2009-3.2-6: Scoping study to address the methodological challenges
of quantifying the socio-economic burden of brain diseases in the enlarged
European Union compared to other major diseases. FP7-HEALTH-2009-
single-stage. The project should include data collection from primary sources and
analysing of the incidence, economic and social costs of brain diseases. Funding
scheme: Coordination and Support Action (Supporting Action).
See also topics HEALTH-2009-4.3.2-2: Access to medicines (SICA) and
HEALTH-2009-4.3.2-3: Integration of Disease Surveillance and Health
Systems Response (SICA).
FP7 Cooperation Work Programme: Health
3.3. ENHANCED HEALTH PROMOTION AND DISEASE PREVENTION
The objective of this area is to provide scientific evidence for the best public health
measures in terms of life styles, work and living circumstances and interventions at
different levels and in different contexts. Focus will be on the wider determinants of health
and how on the basis of new knowledge they interact at both the individual and community
level (e.g. diet, stress, tobacco, alcohol and other substances, physical activity, cultural
context, socio-economic and environmental factors). In particular, mental health will be
addressed in a life-course perspective.
Expected impact: Projects should advance the state of the art in the field of health
promotion and primary prevention research and enhance cooperation between researchers
in Europe and other geographic regions to promote integration and excellence of European
research in the area. This research should provide the evidence base to empower the
individual to change and sustain healthy behaviour and the policy and decision makers at
European, national and local level to develop and implement effective public health
interventions and incorporate health goals in the definition and implementation of all
policies. Findings should be applicable to the general population and be validated in
different settings, translating research into practice. Where applicable scientific
methodologies that allow tools for benchmarking and comparative analysis at the European
level will be considered an asset.
2008-12-03 00:00
The objective is to provide, in the light of new knowledge, scientifically validated tools to
allow countries to learn from the experience of other health systems and their
sustainability, taking into account the importance of national contexts and population
characteristics (ageing, mobility, migration, education, socioeconomic status and the
changing world of work etc). Focus will be on organisational, financial and regulatory
aspects of health systems (assessing the cost, efficiency and benefits of different
interventions including as regards patient safety), their implementation and their outcomes
in terms of effectiveness, efficiency and equity (including disadvantaged groups). Special
attention will be paid to investment issues and human resources, including home care
strategies.
Expected impact: Projects should advance the state of the art in the field of health systems
research and enhance cooperation between researchers in Europe and other geographic
regions to promote integration and excellence of European research in the field. This
research should develop the scientific evidence base that supports the Member States to
organise better their health systems according to the common principles of equity,
solidarity, and universality. The knowledge generated should empower the policy and
decision maker better to manage and reform healthcare systems in view of common
challenges and within the common framework of the European Union.
Topics for single-stage submission and evaluation; deadline 3 December 2008:
- HEALTH-2009-3.2-1: Organisation of dementia care. FP7-HEALTH-2009-
single-stage. Assess European health and social care systems as regards the
organisation and financing of prevention, diagnosis, medical treatment and social
care for dementia patients. Identify/develop approaches/models that can be
integrated into existing European health and social care systems which addresses
the need for specific care and living conditions, the specificities of formal and
informal care arrangements, and supports families living with dementia patients
for more effective and sustainable dementia care in Europe. Findings of this
research should enable national decision makers to base their decisions on the best
knowledge available when they reform the organisation of dementia care.
Funding scheme: Collaborative Project (Small or medium-scale focused research
project).
- HEALTH-2009-3.2-2: Healthcare outcomes and cost-benefits. FP7-HEALTH-
2009-single-stage. Investigate the relationship between quality of care with costs,
efficiency, and accessibility by identifying and assessing existing approaches.
Develop/identify approaches/models to describe the balance between quality of
care and costs, taking patient satisfaction and the benefits of healthcare into
account. Analyse how the transition of changing treatment practice is tackled
across Europe. A multi level approach is needed, also taking into account the
diversity of European health systems (e.g. degree of centralisation, models of
financing, and cultural and historical determinants of models). Findings should
support national decision makers when reforming health systems and aim to
support development of the European Community Health Indicators managed by
the European Commission's Directorate-General for Health and Consumer
FP7 Cooperation Work Programme: Health
Page 31 of 62
Protection. Funding scheme: Collaborative Project (Small or medium-scale
focused research project).
- HEALTH-2009-3.2-3: Primary care quality linkage to costs. FP7-HEALTH-
2009-single-stage. The focus should be on the analysis of different organisational
models for primary care treatment across Europe and to develop models linking
the quality of care to costs, taking into account access, self payment, equity issues
and patient satisfaction. Relationship between primary and secondary care should
be explored including different models of 'gate keeping', and how quality and costs
in primary care are affected. Recommendations on best practice should be
developed and results should support Member States when they reform the
organisation of primary care. Funding scheme: Collaborative Project (Small or
medium-scale focused research project).
- HEALTH-2009-3.2-4: Impact of cross border collaboration on health
services. FP7-HEALTH-2009-single-stage. Identify and analyse arrangements of
cooperation between actors located in different EU countries that aim to transfer
patients, providers, products, services, funding or knowledge across the border
which separates them. Current gaps in documentation of already existing crossborder
collaboration activities as regards geographical coverage, availability and
quality of data need to be addressed. On this basis a systematic in-depth analysis
of the potential impact of cross-border collaboration on the wider healthcare
system should be undertaken. Primary data collected in this project should close
existing gaps and the findings of this research should enable national and
European decision makers to correctly assess the scale of existing cross border
care cooperation and its potential implications for the national healthcare system.
Funding scheme: Collaborative Project (Small or medium-scale focused research
project).
- HEALTH-2009-3.2-5: Research access to comparable healthcare data. FP7-
HEALTH-2009-single-stage. Identify and analyse the availability and
comparability of healthcare related data and the access for health services
researchers to this data across EU member states. Develop recommendations to
improve access to healthcare related data for health services researchers taking into
account national barriers and opportunities for more effective comparative crossnational
health systems research. Account should be taken of existing data (e.g. as
maintained by OECD, WHO, EUROSTAT). Funding scheme: Coordination and
Support action (Coordinating action).
- HEALTH-2009-3.2-6: Scoping study to address the methodological challenges
of quantifying the socio-economic burden of brain diseases in the enlarged
European Union compared to other major diseases. FP7-HEALTH-2009-
single-stage. The project should include data collection from primary sources and
analysing of the incidence, economic and social costs of brain diseases. Funding
scheme: Coordination and Support Action (Supporting Action).
See also topics HEALTH-2009-4.3.2-2: Access to medicines (SICA) and
HEALTH-2009-4.3.2-3: Integration of Disease Surveillance and Health
Systems Response (SICA).
FP7 Cooperation Work Programme: Health
3.3. ENHANCED HEALTH PROMOTION AND DISEASE PREVENTION
The objective of this area is to provide scientific evidence for the best public health
measures in terms of life styles, work and living circumstances and interventions at
different levels and in different contexts. Focus will be on the wider determinants of health
and how on the basis of new knowledge they interact at both the individual and community
level (e.g. diet, stress, tobacco, alcohol and other substances, physical activity, cultural
context, socio-economic and environmental factors). In particular, mental health will be
addressed in a life-course perspective.
Expected impact: Projects should advance the state of the art in the field of health
promotion and primary prevention research and enhance cooperation between researchers
in Europe and other geographic regions to promote integration and excellence of European
research in the area. This research should provide the evidence base to empower the
individual to change and sustain healthy behaviour and the policy and decision makers at
European, national and local level to develop and implement effective public health
interventions and incorporate health goals in the definition and implementation of all
policies. Findings should be applicable to the general population and be validated in
different settings, translating research into practice. Where applicable scientific
methodologies that allow tools for benchmarking and comparative analysis at the European
level will be considered an asset.
WEKOMS 
